Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04547803 · ClinicalTrials.gov registry record · NA
Post-discharge Early Assessment With a Video-visit
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,190
- Enrollment target
NCT04547803: Completed NA study, sponsored by Mayo Clinic.
NCT04547803 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 1,190 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04547803, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,190 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a video visit with an advanced practice provider (Nurse Practitioner or Physician Assistant) within 7 days of discharge from Hospital Internal Medicine services will increase patient compliance with medication, self-management and home supports after hospital discharge.
Primary Outcome
Number of participants to adhere to post-discharge recommendation including medication compliance, self-management, and home supports post hospital discharge
Interventions
- OTHER Standard of Care
- OTHER Video Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,190 participants |
| Start Date | 2020-08-10 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
What the finished NCT04547803 record still lists
NCT04547803 is an interventional study that assigns participants to a tested intervention. Its 1,190 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04547803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04547803 about?
NCT04547803 is a clinical study titled "Post-discharge Early Assessment With a Video-visit". The purpose of this study is to determine if a video visit with an advanced practice provider (Nurse Practitioner or Physician Assistant) within 7 days of discharge from Hospital Internal Medicine services will increase patient compliance with medication, self-management and home supports after hosp...
What is the current status of trial NCT04547803?
This trial is currently completed. It is a NA study. The enrollment target is 1,190 participants. The study started on 2020-08-10. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04547803?
The interventions under investigation include: Standard of Care (OTHER), Video Visit (OTHER).
Who is sponsoring clinical trial NCT04547803?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04547803's enrollment target sits among peer trials
1,190 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI